Background
==========

Human papillomavirus (HPV) infection has always been the focus of public health worldwide. Current data from the United States centers for disease control and prevention (CDC) indicated that nearly 80 million Americans are currently infected with some type of HPV, and about 14 million Americans become infected each year (*<https://www.cdc.gov/hpv/>*). HPV infection has been confirmed to be closely related to the onset of various tumors, including cervical cancers (91%), vulvar cancers (69%), vaginal cancers (75%), penile cancers (63%), anal cancers in females (93%), and oropharyngeal cancers (63%) in females \[[@b1-medscimonit-26-e921571]\]. Although numerous evidences support that vaccination is an effective measure to control the prevalence of HPV, the HPV vaccination rates are relatively low even in the United States \[[@b1-medscimonit-26-e921571]--[@b4-medscimonit-26-e921571]\]. In this context, blocking HPV prevalence must be considered in addition to vaccination and etiological prevention.

Several studies have reported the link of dietary intake of selected nutrients to HPV infection. They have indicated that plant-based foods are negative associate with HPV infection, such as folate, vitamins A, C, and E, and the active Vitamin D \[[@b5-medscimonit-26-e921571]\]. To our best knowledge, literature with respect to the association between dietary calcium (DCa) intake and HPV infection is limited. Results from *in vitro* experiments indicated that extracellular high calcium is associated with HPV persistent infection and progression \[[@b6-medscimonit-26-e921571]--[@b12-medscimonit-26-e921571]\]. In addition, findings from epidemiological survey reported that calcium was negatively associated with a risk of CINII/III \[[@b13-medscimonit-26-e921571]\]. Although these studies aimed at different subjects and did not concern with the association between dietary calcium and HPV prevalence, at least the following assumption can be proposed: DCa intake may be associated with HPV infection and DNA types.

Therefore, in the present study, we used existing National Health and Nutrition Examination Survey (NHANES) data to investigate the correlation of dietary calcium intake on HPV infection in American females with age of 18 to 59 years old.

Material and Methods
====================

Data source
-----------

The National Health and Nutrition Examination Survey (NHANES), a cross-sectional observational study, was designed to investigate the health and nutritional status in American adults and children. It is a continuous program with about 5,000 people involved each year. NHANES data set include demographic, socioeconomic, dietary, health-related questions, physiological measurements and laboratory tests. The introduction of NHANES can be obtained in detail at official website (*<https://www.cdc.Gov/nchs/nhanes/about_nhanes.htm>*).

Participants selection and Ethics statement
-------------------------------------------

We performed a secondary analysis based on NHANES data from 2003 to 2016 (7 circles: 03--04, 05--06, 07--08, 09--10, 11--12, 13--14, 15--16). Initially, a total of 71,058 noninstitutionalized civilians during 2003--2016 were involved. Of these 71,058 participants, we excluded participants who did not meet our inclusion criteria: male (n=35,122), age under 18 years (n=14 343, data were unavailable), 59 years old and older (6,752, no records), females without data of HPV testing (n=690), and missing of DCa values (n=676). Finally, a total of 13,475 participants were used for the final data analysis to explore the association of dietary intake and calcium with HPV infection ([Figure 1](#f1-medscimonit-26-e921571){ref-type="fig"}). National Center for Health Statistics (NCHS) approved this observational study, and all participants signed the informed consent form. The Institutional Review Board Approval can be downloaded from CDC official website (*<https://www.cdc.gov/nchs/nhanes/about_nhanes.htm>*).

Variables involved in the present work
--------------------------------------

### The interested independent variable

In this study, we used the calcium intake in the dietary data as interested independent variable and recorded as a continuous variable. The detailed process of dietary data measurement is described in the NHANES database official website (*<https://www.cdc.gov/nchs/nhanes/ContinuousNhanes/Default.aspx>*).

### The outcome variable

In our present work, we used HPV infection status (dichotomous variable, HPV positive=1; HPV negative=0) and HPV subtype (dichotomous variable, high risk subtype=1; low risk subtype=0) as outcome variables. The test of HPV infection was described in detail in NHANES official website. The subtype of HPV was redefined by the data of HPV DNA typing.

### The covariates involved in this secondary analysis

The covariates involved in this study can be summarized into 5 categories, which are: sociodemographic data, dietary data, laboratory data, questionnaire data, and physical examination data. The selection of covariates was mainly based on previous literature, including factors that are known to be associated with HPV infection or DCa intake \[[@b5-medscimonit-26-e921571],[@b14-medscimonit-26-e921571]--[@b23-medscimonit-26-e921571]\]. Therefore, following covariates were selected for multivariate model construction:

Continuous variables included: 1) body mass index (BMI, kg/m^2^); 2) age (year); 3) frequency of drinking in the past 12 months (time); 4) sex behavior (number of vaginal or anal sex in the past year; number of sexual partners); 5) dietary vitamin B6 intake (mg); 6) folate intake (mcg); 6) vitamin B12 intake (mcg), 7) vitamin C intake (mg); 8) serum vitamin D level (ng/mL), and 9) albumin-adjusted calcium.

Categorical variables included: 1) history of taking contraceptives (yes/no); 2) female sex hormone user (yes/no); 3) race (Mexican American, Other Hispanic, Non-Hispanic White, Non-Hispanic Black, Other Race); 4) education level (less than high school diploma, high school, more than high school diploma); 5) marital status (married or living with partner, single); 6) smoking more than 100 cigarettes in life (yes/no); and 7) poverty income ratio (0--4.99/\>5).

Statistical analysis
--------------------

The statistical analyses were guided according to the guideline provided by the CDC official website (*<https://www.cdc.gov/nchs/nhanes/tutorials/default.aspx>*). Due to the distribution of dietary data were skewed distribution among selected participants, we therefore converted them using the log2 function for subsequent data analysis. To estimate the differences of HPV infection and covariates among different DCa (quartile), weighted chi-square test (categorical variables) or weighted linear regression model (continuous variables) were performed. The entire process of data analyses included 3 aspects with linear association exploration on HPV infection and DCa, nonlinearity addressing and sensitivity analyses. For linear association exploration, weighted binary logistic regression model were used. We built 3 models in this study, they are: non-adjusted model (no covariates were adjusted), minimally-adjusted model (only adjusted sociodemographic data), and fully-adjusted model (all covariates presented in [Table 1](#t1-medscimonit-26-e921571){ref-type="table"}). Model-based odds ratios (OR) and 95% confidence intervals (CI) were recorded. For nonlinearity addressing, generalized additive model and smooth curve fitting (penalty spline method) were used. If nonlinear relationship between DCa and HPV infection was found, we first used recursive algorithm to get the inflection point, and then established a weighted two-piecewise binary logistic regression model on both sides of inflection point. The purpose of sensitivity analyses in the present work was to ensure the robustness of our findings. Firstly, we converted DCa from continuous variable into categorical variable according to quartile, and calculated *P* for trend. It was aimed to observe whether the trend of nonlinear relationship exists by observation of OR values among different groups. Secondly, in order to ensure that the relationship between all independent variables and the dependent variables in the model is linear. Therefore, we used the generalized additive model (GAM) model to adjust all the continuous variables in the covariate (assuming that these variables are nonlinearly related to HPV infection), and also compared the trends of OR between binary logistic regression and GAM models.

On average, covariates had no record in all covariates ([Supplementary Tables 1](#s1-medscimonit-26-e921571){ref-type="supplementary-material"} and [2](#s2-medscimonit-26-e921571){ref-type="supplementary-material"}). For these missing records of covariates, we used dummy variables to indicate missing covariates values. We assigned missing record for each covariate to 0, and additionally created a dummy variable (0=without missing; 1=missing). Both variables entered in the model at the same time (Y=ax1+b\*dummy variable) \[[@b24-medscimonit-26-e921571]\].

All analyses were performed using statistical software R (*<http://www.r-project.org>*, The R Foundation) and EmpowerStats (*<http://www.empower-stats.com>*, X&Y Solutions, Inc., Boston, MA, USA). A *P*-value of less than 0.05 (2-sided) was considered statistically significant.

Results
=======

Baseline characteristics of participants
----------------------------------------

We listed the differences of HPV infection, HPV subtype and covariates among different DCa intake groups (quartile) shown in [Table 1](#t1-medscimonit-26-e921571){ref-type="table"}. No significant differences were detected on BMI, frequency of sex behavior, alcohol consumption, number of sex partners, and HPV subtype. Compared to the Q1, Q2, and Q3 group participants, the participants in Q4 group was younger, had higher intake of vitamin B6, folate, B12 and C, had higher levels of serum vitamin D and albumin-adjusted calcium, and reported more contraceptive and female hormone users. Most of the participants in the Q4 group were Non-Hispanic White. Besides, fewer single females were observed than those of in the Q1 to Q3 groups. Finally, these participants in the Q4 group showed lower rates of HPV infection than the other groups.

Linear association between DCa intake and HPV infection status using univariate and multivariate analyses
---------------------------------------------------------------------------------------------------------

Model-based ORs and 95% CIs are listed in [Table 2](#t2-medscimonit-26-e921571){ref-type="table"}. When no covariates were adjusted, one unit increase of log2 calcium intake was associated with the 11% reductions of risk of HPV infection (OR: 0.89; 95% CI: 0.86--0.92). The same trend was observed on minimally adjusted model (OR: 0.95; 95% CI: 0.91--0.99). However, when we adjusted for all covariates presented in [Table 1](#t1-medscimonit-26-e921571){ref-type="table"}, the linear associated was not observed (OR: 0.93; 95% CI: 0.82--1.05). For HPV subtype, the DCa intake was not associated with HPV subtype, and supported by all models.

Sensitivity analyses with GAM model and *P* for trend indicated that the findings of fully-adjusted model were robust. Firstly, the OR and confidence interval in the GAM model was almost identical to the fully-adjusted model. Besides, *P* for trend was consistent with DCa when it was used as a continuous variable. However, we also found that the OR values in different calcium intake groups were non-equidistant change (ref in Q1 versus 1.23 in Q2 versus 1.18 in Q3 versus 1.24 in Q4). Therefore, the nonlinearity addressing was needed.

In the GAM model, all covariates which recorded as continuous variables were adjusted as nonlinearity.

Nonlinearity of DCa intake on HPV infection
-------------------------------------------

By generalized additive model and smooth curve fitting (penalty spline method), the saturated effect was found on DCa and HPV infection ([Figure 2](#f2-medscimonit-26-e921571){ref-type="fig"}), the inflection point was 9.78 of log2 calcium intake. At the range of 3.32--9.78 of log2 calcium intake, the log2 calcium intake was negatively associated with HPV infection (OR: 0.83; 95% CI: 0.70--0.98). However, when log2 calcium intake exceed 9.78 (range: 9.78--12.64), the association of them cannot be observed (OR: 1.18; 95% CI: 0.91--1.51). For the result of HPV subtype, we did not find the non-linear linking of DCa and HPV subtype ([Table 3](#t3-medscimonit-26-e921571){ref-type="table"}).

Discussion
==========

This large-scale and ongoing cross-sectional survey investigated the association of DCa intake with HPV infection status from 2003 to 2016 (7 cycles). Our findings indicated that DCa intake was not independently associated with HPV infection status, including whether HPV duration (negative/positive) or risk type (high or low). However, we found saturated effect on DCa and HPV infection. At the range of 3.32--9.78 of log2 calcium intake, a unit increase of log2 calcium intake was associated with the 17% decrease of HPV infection.

Due to the lack of researches on discovering the association between DCa and HPV infection status, the explanation of our findings from mechanism is needed. Previous studies have indicated that dietary nutrients, especially plant-based food are associated with HPV acquisition and persistence among women, such as folate and vitamins B6 and B12 \[[@b5-medscimonit-26-e921571]\]. These researches attributed the HPV infection-prevented effect of folate, vitamin B6 and B12 to viral integration regulation, DNA synthesis and repair and methylation, antioxidant \[[@b5-medscimonit-26-e921571]\]. Therefore, calcium with the same effect may explain, in part, why calcium is negatively correlated with HPV infection in our results. Michael Fenech, et al. \[[@b25-medscimonit-26-e921571]\] suggested that low DCa intake was associated with higher genome damage rate. Besides, they also pointed out that calcium can restrain cell proliferation, and induces apoptosis and cell differentiation, which were associated with viral integration regulation \[[@b25-medscimonit-26-e921571]\]. The same finding also has been reported by another researcher \[[@b26-medscimonit-26-e921571]\].

Calcium plays an important role in oxidative stress. Previous studies have demonstrated that calcium intake can lead to the modulation of oxidative stress by modulation of calcium transport and signaling lines \[[@b27-medscimonit-26-e921571]\]. Animal experiment with aP2-agouti and wild-type mice show that calcium exerts sustained effects resulting in attenuated adiposity, protection against age-related muscle loss and reduction of oxidative and inflammatory stress in both mouse strains \[[@b28-medscimonit-26-e921571]\]. Another 2 animal studies also suggested that supplemented with calcium can prevent oxidative stress in rats with aldosteronism, and restrict dietary calcium intake can lead to increased oxidative stress and compensatory upregulation of antioxidant enzymes \[[@b29-medscimonit-26-e921571],[@b30-medscimonit-26-e921571]\].

A series of *in vitro* experiments seem to find similar trends: extracellular high calcium can increase HPV virus transcription, which may be one of the factors that cause HPV persistent infection and cancerous (for example: NRIP and calcium/calmodulin activates the phosphatase calcineurin to dephosphorylate E2 and increase E2 protein stability) \[[@b6-medscimonit-26-e921571]--[@b12-medscimonit-26-e921571]\]. However, a result from an epidemiological survey is contrary to these *in vitro* studies. Hwang et al. \[[@b13-medscimonit-26-e921571]\] found that calcium (OR, 0.21; 95% CI, 0.08--0.50) was significantly associated with a lower risk of CINII/III. We speculated that the inconsistency between the results of *in vitro* experiments and clinical research may cause by the different research subjects and treatment plans. In addition, these studies focus on the outcome after HPV infection, and we focused on the prevalence of HPV. Therefore, higher-level clinical studies (cohort studies) and mechanism-driven studies are needed to further validate our findings and explore hidden mechanisms in the future.

The clinical value of this study includes: 1) to our best knowledge, it is first time to investigate the association between DCa intake and HPV infection and HPV subtype. This will provide new insights and advice for the development of HPV's etiology, epidemiology prevention, and health policy making, that is, DCa intake is a non-negligible factor for HPV infection. The findings of our present work have identified a novel association between DCa intake and HPV infection. It may generate a series of hypotheses that need to be tested systematically by animal models and larger-scale observational studies. These studies should include recommendation of optimal DCa intake, and they make the optimal intake levels for HPV infection prevention can be reliably determined, and the investigation of underlying mechanism.

Our secondary analysis had the following strengths: 1) since the missing data of each covariate is non-randomly missing, we did not use multiple imputation, but used dummy variables to adjust them to minimize the bias caused by missing variables. This method is also used for in a large sample of observational study \[[@b24-medscimonit-26-e921571]\]. 2) The clarification of the nonlinear relationship and the determination of the inflection point have improved the clinical value of our results. In fact, the presence of threshold and saturation effects in most biomedical studies is very common because the human body has its limits and self-regulated instinct. 3) Sensitivity analysis ensures the stability of the results and avoids the contingency in data analysis. 4) Based on a relatively large sample size, we have developed more adequate adjustment strategies, such as folic acid, vitamin B6, B12, and vitamin C, which are recognized as variables associated with HPV infection in previous studies, this adjustment makes our results reliable.

However, the explanation of our findings has some limitations. Firstly, due to NHANES restrictions, we were unable to obtain data on HPV infection in children, so this result could not be used in children. Secondly, this study is limited to American women and therefore it has ethnic and geographical restrictions. Thirdly, the inherent limitations of the cross-sectional study are doomed to the fact that we were unable to obtain an exact causal relationship, resulting in weaker evidence. Fourthly, the variable of "Number of induced abortions" is well-known as a high-risk factor for HPV infection. However, this variable was not included in NHANES database and was not adjusted. Fifthly, the variable of "Number of sex partner" was missing (missing: 7,244, not missing 6,231), but a sensitivity analysis indicated that adjusting or not adjusting this variable has little effect on the association between final dietary calcium and HPV prevalence (see [Supplementary Table 3](#s3-medscimonit-26-e921571){ref-type="supplementary-material"} for details). Finally, in this study, although multiple regression equations were used to adjust for possible potential confounders, adjustments were not possible for those unmeasurable confounders.

Conclusions
===========

In conclusion, we found a saturated effect of DCa intake and HPV infection. In a certain interval (3.32--9.78 of log2 calcium intake), DCa intake was independently and negatively correlated with HPV infection. After this interval, even if the amount of DCa increases, the risk of HPV infection will not decrease further. In addition, DCa intake levels were not associated with HPV subtype of DNA.

Supplementary Data
==================

###### 

The description of missing data.

  Variables                                        Without missing[\*](#tfn4-medscimonit-26-e921571){ref-type="table-fn"}   Missing
  ------------------------------------------------ ------------------------------------------------------------------------ ---------
  Age                                              13475                                                                    0
  Race                                             13475                                                                    0
  Education level                                  12758                                                                    717
  Marital status                                   13404                                                                    71
  BMI                                              13367                                                                    108
  Poverty income ratio                             13190                                                                    285
  History of takingcontraceptives                  12855                                                                    620
  Female sex hormone user                          11546                                                                    1929
  Smoking more than 100 cigarettes in life         13029                                                                    446
  Frequency of drinking in the past 12 months      9813                                                                     3662
  Number of vaginal or anal sex in the past year   7810                                                                     5665
  Number of sexual partners in the past year       6231                                                                     7244
  Dietary vitamin B6 (mg) intake                   13453                                                                    22
  Dietary folate intake (mcg)                      13452                                                                    23
  Dietary vitamin B12 intake (mcg)                 13413                                                                    62
  Dietary vitamin C intake (mg)                    13398                                                                    77
  Serum vitamin D level (ng/mL)                    11543                                                                    1932
  Albumin-adjusted calcium                         13441                                                                    64

From the description of missing data, the number of missing data were mainly in sex behaviors.

###### 

Distribution of missing data on HPV infection status of frequency of drinking in past 12 months, number of vaginal or anal sex in past year and number of vaginal or anal sex in past year.

  HPV infection                                                    Negative        Positive        P-value
  ---------------------------------------------------------------- --------------- --------------- ---------
  Frequency of drinking in the past 12 months                                                      \<0.001
   Without missing                                                 5383 (67.43%)   4430 (80.66%)   
   Missing record                                                  2600 (32.57%)   1062 (19.34%)   
  Number of vaginal or anal sex in the past year                                                   \<0.001
   1                                                               154 ( 1.93%)    111 ( 1.81%)    
   2                                                               152 ( 1.90%)    157 ( 2.55%)    
   12--51                                                          910 (11.40%)    902 (14.67%)    
   52--103                                                         1499 (18.78%)   1161 (18.88%)   
   104--364                                                        896 (11.22%)    692 (11.26%)    
   ≥365                                                            558 ( 6.99%)    525 ( 8.54%)    
   0                                                               43 ( 0.54%)     50 ( 0.81%)     
   Missing record                                                  3771 (47.24%)   1894 (34.49%)   
  Number of sexual partners in the past year (no of sample size)                                   \<0.001
   Without missing                                                 3396 (42.54%)   2835 (46.11%)   
   Missing record                                                  4587 (57.46%)   2657 (48.38%)   

HPV -- human papillomavirus.

###### 

Results of sensitivity analysis with strategy of adjustment.

  Outcome                                       HPV infection status[\*](#tfn6-medscimonit-26-e921571){ref-type="table-fn"} OR, 95% CI   HPV subtype OR, 95% CI   HPV infection status OR, 95% CI[\*](#tfn6-medscimonit-26-e921571){ref-type="table-fn"}   HPV subtype OR, 95% CI[\*](#tfn6-medscimonit-26-e921571){ref-type="table-fn"}
  --------------------------------------------- ---------------------------------------------------------------------------------------- ------------------------ ---------------------------------------------------------------------------------------- -------------------------------------------------------------------------------
  Fitting by binary logistic regression model   0.93 (0.82, 1.05)                                                                        1.09 (0.93, 1.28)        0.95 (0.86, 1.05)                                                                        1.09 (0.96, 1.24)
  Fitting by weighted two piecewise model                                                                                                                                                                                                                  
   Inflection point                             9.78                                                                                     10.3                     10.02                                                                                    7.9
   \<Inflection point                           0.83 (0.70, 0.98)                                                                        1.07 (0.89, 1.28)        0.89 (0.79, 1.00)                                                                        0.76 (0.45, 1.29)
   ≥Inflection point                            1.18 (0.91, 1.52)                                                                        1.27 (0.70, 2.31)        1.19 (0.93, 1.53)                                                                        1.13 (0.99, 1.30)
   Log likelihood ratio test                    0.037                                                                                    0.597                    0.048                                                                                    0.155

Indicated the variable of "number of sexual partners in the past year" was included in model. We can observe that except for HPV genotype changes (because missing data is more obvious), the results of HPV infection status (infection/non-infection) have hardly changed (except for the credibility caused by excessive sample loss beyond widening). HPV -- human papillomavirus; OR -- odds ratio; CI -- confidence interval.
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![(**A**) The association between dietary calcium intake and human papillomavirus (HPV) infection status is a non-linear relationship. (**B**) There is a non-linear association between dietary calcium intake and HPV infected person type.](medscimonit-26-e921571-g002){#f2-medscimonit-26-e921571}

###### 

The differences of HPV infection and covariates among different groups of dietary calcium intake.

                                                                     Dietary calcium intake mg/per day log2 transform                                             
  ------------------------------------------------------------------ -------------------------------------------------- ------------- ------------- ------------- ---------
  BMI, mean±SD, kg/m^2^                                              28.99±7.46                                         29.40±7.81    29.06±7.76    29.11±7.85    0.136
  Age, mean±SD, year                                                 37.08±12.81                                        37.34±12.32   37.26±12.19   35.79±11.96   \<0.001
  Frequency of drinking in the past 12 months, mean±SD, time         3.00±9.13                                          3.16±9.49     3.30±9.09     3.51±14.66    0.408
  Number of vaginal or anal sex in the past year, mean±SD, (times)   1.40±3.14                                          1.42±4.25     1.32±3.11     1.36±2.42     0.869
  Dietary vitamin B6, mean±SD, mg                                    −0.05±1.01                                         0.44±0.80     0.67±0.74     1.01±0.71     \<0.001
  Dietary folate, mean±SD, mcg                                       6.64±0.99                                          7.23±0.78     7.48±0.75     7.83±0.71     \<0.001
  Dietary vitamin B12, mean±SD, mcg                                  0.60±1.48                                          1.41±1.06     1.89±0.92     2.44±0.84     \<0.001
  Dietary vitamin C, mean±SD, mg                                     4.68±2.07                                          5.30±1.86     5.65±1.70     6.11±1.68     \<0.001
  Serum vitamin D level, mean±SD, ng/mL                              54.37±26.47                                        58.02±26.93   61.64±27.05   65.33±26.82   \<0.001
  Serum albumin-adjusted calcium, mean±SD                            9.25±0.33                                          9.25±0.34     9.25±0.34     9.29±0.35     \<0.001
  History of taking contraceptives                                                                                                                                \<0.001
   No                                                                32.36%                                             28.03%        27.61%        27.53%        
   Yes                                                               67.64%                                             71.97%        72.39%        72.47%        
  Female sex hormone user                                                                                                                                         0.041
   No                                                                87.45%                                             88.86%        88.90%        89.86%        
   Yes                                                               12.55%                                             11.14%        11.10%        10.14%        
  Race                                                                                                                                                            \<0.001
   Mexican American                                                  16.69%                                             18.70%        20.53%        20.46%        
   Other Hispanic                                                    8.15%                                              9.62%         9.18%         8.90%         
   Non-Hispanic White                                                35.47%                                             36.74%        41.78%        46.86%        
   Non-Hispanic Black                                                30.11%                                             25.63%        19.61%        16.99%        
   Other race/ethnicity                                              9.58%                                              9.32%         8.89%         6.79%         
  Education                                                                                                                                                       \<0.001
   \<High school                                                     48.28%                                             44.31%        39.53%        37.32%        
   High school                                                       33.77%                                             33.41%        32.45%        33.88%        
   \>High school                                                     17.95%                                             22.28%        28.02%        28.80%        
  Marital status                                                                                                                                                  \<0.001
   Married or living with partner                                    50.78%                                             56.80%        59.34%        60.44%        
   Single                                                            49.22%                                             43.20%        40.66%        39.56%        
  Smoking more than 100 cigarettes in life                                                                                                                        \<0.001
   No                                                                59.71%                                             63.76%        65.68%        65.49%        
   Yes                                                               40.29%                                             36.24%        34.32%        34.51%        
  Number of vaginal or anal sex in the past year (times)                                                                                                          0.057
   1 time                                                            3.67%                                              2.92%         3.56%         3.46%         
   2 times                                                           4.61%                                              3.50%         4.17%         3.41%         
   12--51 times                                                      25.42%                                             24.32%        21.34%        21.98%        
   52--103 times                                                     31.66%                                             35.59%        34.71%        34.07%        
   104--364 times                                                    19.24%                                             19.36%        20.78%        22.32%        
   ≥365 times                                                        13.99%                                             13.31%        14.33%        13.43%        
   0 times                                                           1.40%                                              0.99%         1.12%         1.33%         
  Poverty income ratio                                                                                                                                            \<0.001
   1                                                                 30.18%                                             26.32%        22.75%        24.94%        
   2                                                                 25.63%                                             23.53%        23.23%        25.25%        
   3                                                                 13.15%                                             13.67%        14.78%        12.85%        
   \>3                                                               31.04%                                             36.47%        39.24%        36.96%        
  HPV infection status                                                                                                                                            \<0.001
   Negative                                                          51.98%                                             56.48%        59.52%        58.16%        
   Positive                                                          48.02%                                             43.52%        40.48%        41.84%        
  HPV subtype                                                                                                                                                     0.514
   Low risk                                                          50.56%                                             49.38%        49.71%        47.84%        
   High risk                                                         49.44%                                             50.62%        50.29%        52.16%        

BMI -- body mass index; HPV -- Human papillomavirus. All dietary data were transformed by log~2~ function.

###### 

Linear association of dietary calcium intake and HPV infection by weighted binary logistic regression model.

  Exposure                               Non-adjusted model OR, 95% CI   Minimally-adjusted model OR, 95% CI   Fully-adjusted model OR, 95% CI   GAM model OR, 95% CI
  -------------------------------------- ------------------------------- ------------------------------------- --------------------------------- ----------------------
  **HPV infection (yes/no)**                                                                                                                     
  Log~2~ dietary calcium intake          0.89 (0.86, 0.92)               0.95 (0.91, 0.99)                     0.93 (0.82, 1.05)                 0.94 (0.83, 1.06)
   Q1                                    Ref                             Ref                                   Ref                               Ref
   Q2                                    0.83 (0.76, 0.92)               0.92 (0.83, 1.03)                     0.84 (0.65, 1.09)                 0.87 (0.67, 1.12)
   Q3                                    0.74 (0.67, 0.81)               0.86 (0.77, 0.96)                     0.76 (0.58, 0.99)                 0.77 (0.59, 1.01)
   Q4                                    0.78 (0.71, 0.86)               0.89 (0.79, 0.99)                     0.88 (0.66, 1.18)                 0.88 (0.65, 1.17)
  *P* for trend                          \<0.0001                        0.0186                                0.4423                            0.3922
  **HPV subgroup (low and high risk)**                                                                                                           
  Log~2~ dietary calcium intake          1.01 (0.96, 1.06)               1.01 (0.95, 1.07)                     1.09 (0.93, 1.28)                 1.09 (0.93, 1.28)
   Q1                                    Ref                             Ref                                   Ref                               Ref
   Q2                                    1.05 (0.91, 1.21)               1.14 (0.98, 1.34)                     1.23 (0.88, 1.72)                 1.22 (0.87, 1.71)
   Q3                                    1.03 (0.90, 1.20)               1.11 (0.94, 1.30)                     1.18 (0.82, 1.70)                 1.18 (0.82, 1.69)
   Q4                                    1.11 (0.97, 1.29)               1.12 (0.95, 1.31)                     1.24 (0.84, 1.83)                 1.23 (0.84, 1.82)
  *P* for trend                          0.1739                          0.2478                                0.3781                            0.3809

Ref -- reference; OR -- odds ratio; CI -- confidence interval. Non-adjusted model -- no covariates were adjusted. Minimally adjusted model -- only sociodemographic data were adjusted. Fully adjusted model -- all covariates were adjusted. GAM model -- all covariates which recorded as continuous variables were adjusted as nonlinearity.

###### 

Further addressing of nonlinearity between dietary calcium intake and HPV infection status.

  Outcome                                       HPV infection status OR, 95% CI   HPV subtype OR, 95% CI
  --------------------------------------------- --------------------------------- ------------------------
  Fitting by binary logistic regression model   0.93 (0.82, 1.05)                 1.09 (0.93, 1.28)
  Fitting by weighted two piecewise model                                         
   Inflection point                             9.78                              10.3
   \<inflection point                           0.83 (0.70, 0.98)                 1.07 (0.89, 1.28)
   ≥inflection point                            1.18 (0.91, 1.52)                 1.27 (0.70, 2.31)
  Log likelihood ratio test                     0.037                             0.597

HPV -- human papillomavirus; OR -- odds ratio; CI -- confidence interval. The adjusted strategy of covariates was the same as fully-adjusted model.
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